BRIEF-Whitehawk Therapeutics Completes Strategic Transformation With Successful Closing Of Sale Of Aadi Subsidiary To Kaken Pharmaceuticals

Reuters
26 Mar
BRIEF-Whitehawk <a href="https://laohu8.com/S/LENZ">Therapeutics</a> Completes Strategic Transformation With Successful Closing Of Sale Of Aadi Subsidiary To Kaken Pharmaceuticals

March 26 (Reuters) - Whitehawk Therapeutics Inc WHWK.O:

  • WHITEHAWK THERAPEUTICS COMPLETES STRATEGIC TRANSFORMATION WITH SUCCESSFUL CLOSING OF SALE OF AADI SUBSIDIARY TO KAKEN PHARMACEUTICALS

Source text: ID:nPn37GL3Na

Further company coverage: WHWK.O

((Reuters.Briefs@thomsonreuters.com;))

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10